Skip to main content
. 2015 Oct 7;7(1):e2015053. doi: 10.4084/MJHID.2015.053

Table 3.

Antibiotic sensitivity and resistance pattern of the CA-MRSA [n=19] and HA-MRSA isolates [n=46].

Antibiotics NHA# CPHA# RHA# NCA# CPCA# RCA# SHA[%] SCA[%]
Erythromycin[%] 10[83] 2[17] 12[100] 10[63] 6[37]* 16[100] 7[37] 30[65]*
Clindamycin[%] 7[88] 1[12] 8[100] 3[60] 2[40]* 5[100] 11[58] 41[89]*
Rifampicin[%] 1[100] 0* 1[100] 0 0* 0 18[95] 46[100]*
Doxycycline[%] 2[100] 0* 2[100] 2[50] 1[50]* 3[100] 17[90] 43[94]*
Vancomycin[%] 3[100] 0* 3[100] 2[50] 2[50]* 4[100] 16[84] 42[91]*
Linezolid[%] 0 0* 0 0 0* 0 19[100] 46[100]*
Teicoplanin[%] 4[100] 0 4[100] 3[75] 1[25]* 4[100] 15[79] 42[91]*

N- Nasal Swab isolates; CP- Cell phone Swab isolates;

#

R-Number [%] of Resistant MRSA isolates;

-S%-Number [%] of sensitive MRSA isolates, CA- Community hospital visitors; HA- Hospital Health-care workers;

S - p<0.05, N v/s CP, Chi square test. ;

*

NS - p<0.05, CA v/s HA, Chi square test.